Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Testing effectiveness (Phase 2)Looking for participantsNCT07047586
What this trial is testing

Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Fudan University 146
Not applicableLooking for participantsNCT07730073
What this trial is testing

Efficacy of LSVT-LOUD Therapy on Voice, Speech, and Quality of Life in Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
Atlas University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677475
What this trial is testing

MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Dongguan People's Hospital 65
Testing effectiveness (Phase 2)Study completedNCT02581657
What this trial is testing

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
PhaseBio Pharmaceuticals Inc. 37
Large-scale testing (Phase 3)Study completedNCT00488839
What this trial is testing

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Impax Laboratories, LLC 173
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Early research (Phase 1)Study completedNCT03655301
What this trial is testing

Effect of Copanlisib on Metformin Pharmacokinetics and Pharmacodynamics

Who this might be right for
Healthy Volunteers
Bayer 13
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT05929339
What this trial is testing

Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin

Who this might be right for
Acute PainChronic PainHealthy Volunteer
Wake Forest University Health Sciences 25
Early research (Phase 1)Study completedNCT01316432
What this trial is testing

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Who this might be right for
Heart FailureADHFChronic Heart Failure+1 more
Nile Therapeutics 58
Testing effectiveness (Phase 2)Ended earlyNCT02938793
What this trial is testing

Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors

Who this might be right for
CancerRare Disease
Prisma Health-Upstate 92
Early research (Phase 1)Study completedNCT03646721
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
Dong-A ST Co., Ltd. 108
Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Testing effectiveness (Phase 2)Study completedNCT04463771
What this trial is testing

Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

Who this might be right for
Endometrial Cancer
Incyte Corporation 206
Early research (Phase 1)Study completedNCT05351671
What this trial is testing

A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS

Who this might be right for
Healthy
ReAlta Life Sciences, Inc. 30
Post-approval studies (Phase 4)Study completedNCT02417246
What this trial is testing

Open-Labeled PK-PD Studies of Metoprolol ER

Who this might be right for
Blood Pressure
University of Florida 61
Early research (Phase 1)Study completedNCT03801902
What this trial is testing

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaLocally Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8+2 more
National Cancer Institute (NCI) 26
Not applicableUnknownNCT04203095
What this trial is testing

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

Who this might be right for
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Not applicableActive Not RecruitingNCT05916157
What this trial is testing

An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
AbbVie 250
Next Page